Oragenics Inc
OGEN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001174940
No open-market purchases or sales by Oragenics Inc insiders were filed in the last 90 days; 17 institutions reported holding it in 13F filings for Q2 2026, worth $39.2K in total; no superinvestor holds it.
13F holders, Q2 2026
Institutional positions in Oragenics Inc as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 17
- −3 vs. Q1 2026
- Shares held
- 67.5K
- −121.9K (−64.3%) vs. Q1 2026
- Total value
- $39.2K
- −$66.6K (−62.9%) vs. Q1 2026
- New holders
- 2
- 3 more added
- Sold out
- 5
- 2 more reduced
Compare with Q1 2026: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting OGEN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 17 | $39.2K |
| Q1 2026 | 20 | $105.8K |
| Q4 2025 | 19 | $169.3K |
| Q3 2025 | 16 | $160.5K |
| Q2 2025 | 18 | $401.6K |
| Q1 2025 | 22 | $57.2K |
| Q4 2024 | 24 | $86.0K |
| Q3 2024 | 16 | $62.2K |
| Q2 2024 | 16 | $135.6K |
| Q1 2024 | 14 | $269.2K |
| Q4 2023 | 15 | $349.5K |
| Q3 2023 | 13 | $182.1K |
| Q2 2023 | 13 | $173.5K |
| Q1 2023 | 14 | $201.0K |
| Q4 2022 | 31 | $1.08M |
| Q3 2022 | 29 | $2.48M |
| Q2 2022 | 29 | $9.98M |
| Q1 2022 | 28 | $3.62M |
| Q4 2021 | 33 | $4.99M |
| Q3 2021 | 29 | $6.82M |
| Q2 2021 | 22 | $6.63M |
| Q1 2021 | 29 | $8.27M |
Institutions, Q2 2026
Shares, value and share of portfolio for each institution holding Oragenics Inc; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 23,685 | $13.8K | 0.00% | −41,387−63.6% | Reduced |
| 25 LLC | 23,160 | $13.4K | 0.00% | +23,160 | New |
| Jane Street Group, LLC | 12,771 | $7.41K | 0.00% | +12,771 | New |
| Tower Research Capital LLC (TRC) | 4,548 | $2.64K | 0.00% | 00.0% | Unchanged |
| St. Johns Investment Management Company, LLC | 1,924 | $1.12K | 0.00% | +1,724+862.0% | Added |
| BlackRock, Inc. | 703 | $408 | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 642 | $373 | 0.00% | −4,563−87.7% | Reduced |
| Wells Fargo & Company | 34 | $20 | 0.00% | 00.0% | Unchanged |
| Harbour Investments, Inc. | 34 | $20 | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 23 | $13 | 0.00% | +12+109.1% | Added |
| Adkins Seale Capital Management LLC | 3 | $2 | 0.00% | 00.0% | Unchanged |
| Johnson Financial Group, Inc. | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Bogart Wealth, LLC | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Strategic Wealth Partners, Ltd. | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Farther Finance Advisors, LLC | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Keating Financial Advisory Services, Inc. | 1 | $1 | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 2 | $0 | 0.00% | +1+100.0% | Added |
| Pathstone Holdings, LLC | 0 | $0 | 0.00% | −55,001−100.0% | Sold out |
| Two Sigma Securities, LLC | 0 | $0 | 0.00% | −20,343−100.0% | Sold out |
| HRT Financial LP | 0 | $0 | 0.00% | −18,672−100.0% | Sold out |
| Virtu Financial LLC | 0 | $0 | 0.00% | −17,575−100.0% | Sold out |
| Ameritas Advisory Services, LLC | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |